Literature DB >> 2854837

[Intra-hepatic artery infusional chemotherapy with cisplatin suspension in lipiodol (LPS) of hepatocellular carcinoma (I)--Preparation of LPS and its anticancer effect on a rabbit liver cancer model after injection into the hepatic artery].

S Fukushima, S Kishimoto, Y Hayashi, M Kaneko, M Nakano, J Shibata, S Fujiyama, T Sato.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2854837

Source DB:  PubMed          Journal:  Nihon Gan Chiryo Gakkai Shi        ISSN： 0021-4671


× No keyword cloud information.
  4 in total

1.  Future perspectives on the treatment of hepatocellular carcinoma with cisplatin.

Authors:  Toru Ishikawa
Journal:  World J Hepatol       Date:  2009-10-31

2.  In vitro antitumor activity, intracellular accumulation, and DNA adduct formation of cis-[((1R,2R)-1,2-cyclohexanediamine-N,N')bis(myristato)] platinum (II) suspended in lipiodol.

Authors:  S Kishimoto; K Miyazawa; S Fukushima; Y Takeuchi
Journal:  Jpn J Cancer Res       Date:  2000-01

3.  Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of tumors implanted in rat livers by inducing platinum-DNA adducts to form and massive apoptosis.

Authors:  Mitsuharu Hanada; Akemi Baba; Yasuyuki Tsutsumishita; Toshihiro Noguchi; Takashi Yamaoka; Nobuyoshi Chiba; Fumio Nishikaku
Journal:  Cancer Chemother Pharmacol       Date:  2008-12-24       Impact factor: 3.333

4.  Phase I clinical study of a novel lipophilic platinum complex (SM-11355) in patients with hepatocellular carcinoma refractory to cisplatin/lipiodol.

Authors:  S Fujiyama; J Shibata; S Maeda; M Tanaka; S Noumaru; K Sato; K Tomita
Journal:  Br J Cancer       Date:  2003-11-03       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.